title: Tafluprost for the reduction of interocular pressure in open angle glaucoma and ocular hypertension.
abstract: Tafluprost is an FP receptor antagonist that has been shown in clinical studies in Europe and Japan to be extremely useful in treating elevated intraocular pressure and glaucoma. The drug is well tolerated and appears to be at least equal in effectiveness and perhaps superior to other protanoids for routine use comparison to be superior to other treatments for the elevated IOP as the side effects and other related symptomology appear to be less, while maintaining a level of pressure control for prolonged periods.
authors.affiliation: Department of Biology, University of Calgary, Calgary, Alberta Canada T2N 1N4 and Biogram Inc., Ponte Vedra Beach, FL 32004, USA.
authors.forename: Clyde
authors.initials: C
authors.lastname: Schultz
keywords: IOP; Tafluprost; drug; glaucoma